RA Biologic ' s Serious Infection Risk Confounded by Order of Use RA Biologic ' s Serious Infection Risk Confounded by Order of Use

The risk for serious infection seen with tocilizumab is confounded by whether the drug is given as first-line or as subsequent treatment in the line of therapy.Medscape Medical News

Source: Medscape Medical News Headlines - April 28, 2021 Category: Consumer Health News Tags: Rheumatology News Source Type: news